BioCentury
ARTICLE | Finance

Ebb & Flow

October 8, 2007 7:00 AM UTC

MannKind (MNKD) has pushed itself closer to the top of a short list of biotech companies that have raised in excess of $1 billion without having a product on the market.

Last week, the company raised $250 million in two registered direct offerings totaling 27 million shares, nudging its total financing to more than $1.4 billion...